St. Renatus has received FDA approval for KOVANAZE (tetracaine HCl and oxymetazoline HCl) nasal spray. This is the first product that allows for dental anesthesia to be administered through a nasal spray without using a needle. KOVANAZE is intended for use in dentistry as a topical anesthetic, delivered in the nasal cavity to achieve pulpal (tooth nerve) anesthesia for the restorative treatment of teeth. Like traditional dental injections, this product delivers a local dental anesthetic but without the needle. KOVANAZE is indicated for regional anesthesia when performing a restorative procedure on teeth Nos. 4 to 13 and A to J in adults and children who weigh 40 kg or more.